Brynne Stanton

Title: Innovations of Brynne Stanton in Biotechnology

Introduction

Brynne Stanton is an accomplished inventor based in Boston, MA (US). She has made significant contributions to the field of biotechnology, particularly in the development of engineered yeast for fermentation processes. With a total of 2 patents, her work is paving the way for advancements in bioproduct generation.

Latest Patents

One of Brynne's latest patents is focused on "Glucoamylase engineered yeast and fermentation methods." This invention involves an engineered yeast that includes an exogenous nucleic acid encoding a glucoamylase comprising SEQ ID NO:1 and SEQ ID NO:4, or a variant thereof. The engineered yeast is capable of providing glucoamylase into fermentation media, which facilitates the degradation of starch material to generate glucose for fermentation into desired bioproducts, such as ethanol. High titers of bioproduct, for example, 70 g/kg of ethanol, can be achieved, along with low residual glucose levels. Additionally, the yeast demonstrates good growth and bioproduct production at temperatures of 32° C. or greater.

Career Highlights

Brynne Stanton is currently employed at Cargill Inc., where she continues to innovate in the field of biotechnology. Her work is instrumental in enhancing fermentation methods and improving the efficiency of bioproduct production.

Collaborations

Brynne collaborates with talented individuals such as Chris Miller and Brian Jeffrey Rush, contributing to a dynamic and innovative work environment.

Conclusion

Brynne Stanton's contributions to biotechnology through her patented inventions are noteworthy. Her work in engineered yeast and fermentation methods is setting new standards in the industry.